Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| European Commission | OTHER |
Not provided
Not provided
Not provided
Not provided
Nowadays, many persons who exercise consume dietary supplements. Previous scientific studies have found that protein supplementation increases muscle mass when combined with an exercise program. In addition, vitamin D probably improves performance and muscle function. Likewise, ω3 fatty acids, apart from improving cardiovascular function, may also increase protein synthesis and performance. Thus, the aim of this study is to investigate the efficacy of a novel aquaculture-based sport supplement of proteins, ω3 fatty acids and vitamin D on physical performance, body composition, and the biochemical profile of persons following high-intensity functional training (HIFT). The efficacy of the experimental supplement (E) will be compared with whey protein (W) and maltodextrin (a carbohydrate) as placebo (P).
Thirty healthy trained individuals (15 male and 15 female), aged 18-35, will take E, W, and P during three 6-week periods of HIFT (a different supplement each period) with three workouts a week and a washout (no supplement) period of 2 weeks between supplementation periods. E is a combination of powder, containing protein and vitamin D, and capsules containing ω3 fatty acids. When on E, participants will receive 0.6 g protein/kg body weight, 20 μg vitamin D, and 1.8 g ω3 fatty acids daily. When on W, they will receive 0.6 g protein/kg body weight and, when on P, they will receive 0.6 g maltodextrin/kg body weight daily. The order of E, W, and P will be random and counterbalanced. Throughout the study, participants will be on isoenergetic nutritional plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day.
Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition prior to the first supplementation period, between periods, and after the third period. Also, blood amino acids, fatty acid acids, vitamin D, hematology, biochemistry, and hormones will be measured. To avoid bias, assessors will not know which supplement each participant is taking during each period.
The main hypotheses of the study are: 1) Consumption of E will increase lean body mass compared to W and P; 2) consumption of E will improve muscle strength, muscle endurance, and aerobic capacity compared to W and P; and 3) consumption of E will result in a better blood amino acid, fatty acid, and vitamin D profile.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fish nutrients - Whey protein - Maltodextrin | Other | Participants will receive fish nutrients, whey protein, and maltodextrin in this order. |
|
| Fish nutrients - Maltodextrin - Whey protein | Other | Participants will receive fish nutrients, maltodextrin, and whey protein in this order. |
|
| Whey protein - Fish nutrients - Maltodextrin | Other | Participants will receive whey protein, fish nutrients, and maltodextrin in this order. |
|
| Whey protein - Maltodextrin - Fish nutrients | Other | Participants will receive whey protein, maltodextrin, and fish nutrients in this order. |
|
| Maltodextrin - Fish nutrients - Whey protein | Other |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fish nutrients | Dietary Supplement | Intake of fish protein, omega-3 fatty acids, and vitamin D |
|
| Measure | Description | Time Frame |
|---|---|---|
| Plasma amino acid profile pre-supplementation | Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry. | Within 2 days before the beginning of supplementation. |
| Plasma amino acid profile post-supplementation | Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry. | Within 2 days after the end of supplementation. |
| Whole-blood fatty acid profile pre-supplementation | Whole-blood fatty acid profile (that is, the concentration of each individual fatty acid) will be determined by gas chromatography. | Within 2 days before the beginning of supplementation. |
| Whole-blood fatty acid profile post-supplementation | Whole-blood fatty acid profile (that is, the concentration of each individual fatty acid) will be determined by gas chromatography. | Within 2 days after the end of supplementation. |
| Maximal dynamic strength of shoulder muscles pre-supplementation | Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum. | Within 2 weeks before the beginning of supplementation. |
| Maximal dynamic strength of shoulder muscles post-supplementation | Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum. | Within 2 weeks after the end of supplementation. |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma vitamin D concentration pre-supplementation | Vitamin D will be measured by liquid chromatography - mass spectrometry. | Within 2 days before the beginning of supplementation. |
| Plasma vitamin D concentration post-supplementation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Laboratory of Evaluation of Human Biological Performance | Thessaloniki | 57001 | Greece |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42189275 | Derived | Kosmidis I, Karpouzi C, Petridou A, Voulgaridou G, Bogdanis GC, Mougios V. Effects of a nutritional supplement containing fish protein, vitamin D, and omega3 fatty acids, taken during high-intensity functional training, on physical performance in recreationally trained individuals: a randomized controlled trial. Eur J Nutr. 2026 May 26;65(4):136. doi: 10.1007/s00394-026-03983-z. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000067816 | Whey Proteins |
| C008315 | maltodextrin |
| ID | Term |
|---|---|
| D008894 | Milk Proteins |
| D000080224 | Animal Proteins, Dietary |
| D004044 | Dietary Proteins |
| D011506 | Proteins |
Not provided
Not provided
Not provided
Not provided
Not provided
Participants are instructed not to disclose the supplement they are taking to their trainers, investigators, or outcome assessors.
Participants will receive maltodextrin, fish nutrients, and whey protein in this order.
|
| Maltodextrin - Whey protein - Fish nutrients | Other | Participants will receive maltodextrin, whey protein, and fish nutrients in this order. |
|
| Whey protein | Dietary Supplement | Intake of whey protein |
|
| Maltodextrin | Dietary Supplement | Intake of maltodextrin |
|
| Force-velocity relationship of knee flexors and extensors pre-supplementation | Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer. | Within 2 weeks before the beginning of supplementation. |
| Force-velocity relationship of knee flexors and extensors post-supplementation | Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer. | Within 2 weeks after the end of supplementation. |
| Aerobic fitness pre-supplementation | Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill. | Within 2 weeks before the beginning of supplementation. |
| Aerobic fitness post-supplementation | Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill. | Within 2 weeks after the end of supplementation. |
| Lean and fat mass pre-supplementation | Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry. | Within 2 weeks before the beginning of supplementation. |
| Lean and fat mass post-supplementation | Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry. | Within 2 weeks after the end of supplementation. |
Vitamin D will be measured by liquid chromatography - mass spectrometry.
| Within 2 days after the end of supplementation. |
| Muscle endurance pre-supplementation | Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions. | Within 2 weeks before the beginning of supplementation. |
| Muscle endurance post-supplementation | Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions. | Within 2 weeks after the end of supplementation. |
| Force-velocity relationship of shoulder muscles pre-supplementation | Force-velocity relationship of shoulder muscles will be assessed by a linear encoder. | Within 2 weeks before the beginning of supplementation. |
| Force-velocity relationship of shoulder muscles post-supplementation | Force-velocity relationship of shoulder muscles will be assessed by a linear encoder. | Within 2 weeks after the end of supplementation. |
| Full blood count pre-supplementation | Full blood count will be performed by flow cytometry. | Within 2 days before the beginning of supplementation. |
| Full blood count post-supplementation | Full blood count will be performed by flow cytometry. | Within 2 days after the end of supplementation. |
| Biochemical analyses pre-supplementation | Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer. | Within 2 days before the beginning of supplementation. |
| Biochemical analyses post-supplementation | Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer. | Within 2 days after the end of supplementation. |
| Plasma enzymes pre-supplementation | Creatine kinase and γ-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer. | Within 2 days before the beginning of supplementation. |
| Plasma enzymes post-supplementation | Creatine kinase and γ-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer. | Within 2 days after the end of supplementation. |
| Hormonal analyses pre-supplementation | Plasma cortisol and testosterone (both in μg/dL) will be measured by immunoluminescence in an automated analyzer. | Within 2 days before the beginning of supplementation. |
| Hormonal analyses post-supplementation | Plasma cortisol and testosterone (both in μg/dL) will be measured by immunoluminescence in an automated analyzer. | Within 2 days after the end of supplementation. |
| Internal load of exercise pre-supplementation | The internal load of exercise will be assessed by telemetric heart rate sensors and software. | Within the first week of supplementation. |
| Internal load of exercise post-supplementation | The internal load of exercise will be assessed by telemetric heart rate sensors and software. | Within the last week of supplementation (week 6). |
| D000602 |
| Amino Acids, Peptides, and Proteins |
| D000067796 | Whey |
| D008892 | Milk |
| D003611 | Dairy Products |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D019602 | Food and Beverages |